Virus-Enhanced 2D Nanomaterial for Targeted Cancer Ablation
SUTD Researchers Developed Novel 2D Material with Virus to Kill Cancer Cells
Tags: Singapore University of Technology and Design, Singapore, Healthcare & Lifesciences
SUTD researchers in collaboration with Changi General Hospital and A*Star developed a novel 2D nanomaterial using MoS2 and the M13 virus to enhance electro-thermal cancer therapy. This hybrid material, termed MNM, targets pancreatic cancer cells with high specificity, heating up via electrical pulses to kill a larger number of cells with improved bio-compatibility. Applications include precise, non-invasive cancer cell ablation in difficult-to-treat cancers. MNM’s unique structure doubles the effectiveness of current nano-therapies, destroying 23% of cancer cells compared to traditional methods. This innovation holds promise for more effective, targeted cancer treatments.
IP Type or Form Factor: Material
TRL: 3 - proof of concept with needs validated
Industry or Tech Area: Biotechnology; Pharmaceutical Engineering
